The US Food and Drug Administration (FDA) has granted 510k clearance to Germany-based medical technology company Fiagon’s brain navigation software.

The FDA clearance encompasses the company’s navigation system and software, BiopsyPointer FlexPointer 1.5 and ShuntPointer.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Fiagon’s Navigation system uses an electromagnetic tracking system to detect surgical instruments during surgery related to the patient’s CT scan.

"Fiagon’s smart system with a small footprint, enables surgeons to increase patient safety during standard and critical brain surgeries."

Fiagon’s technology features instruments which leverage on the company’s patented ‘chip on the tip’ technology, including bendable instrumentation to provide access to the challenging anatomy.

The use of surgical navigation tools enables surgeons to reduce the risk to patients and decrease surgery time by reducing the number of instrument changes.

See Also:

Fiagon president Wolfgang Urbild said: "With the new regulatory clearance we will bring a wider range of surgical navigation tools to surgeons in the US and continue our expansion in the North American market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"Fiagon’s smart system with a small footprint, enables surgeons to increase patient safety during standard and critical brain surgeries."

Fiagon’s navigation set for brain interventions is designed to allow surgeons flexibility and easier navigation of craniotomies, scull base procedures, cranial biopsies and general catheter placement.

The technology includes the Navigation module with Navigation software; navigation sensor; navigation instrument; patient reference localiser; ShuntPointer; FlexPointer 1.5; BiopsyPointer.

The Brain navigation system and instrument set have previously received regulatory clearance in EMEA, Australia and Russia. It is currently marketed in more than 50 countries.